Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA structure/function claim substantiation guidance advised by FTC staff.

This article was originally published in The Tan Sheet

Executive Summary

FDA STRUCTURE/FUNCTION CLAIM SUBSTANTIATION GUIDANCE ADVISED BY FTC Bureau of Consumer Protection staff in Aug. 27 comments to FDA. The Federal Trade Commission division urges in comments on FDA's April 29 proposed rule on the claims for dietary supplements that "any final rule reiterate explicitly the requirement" in the Dietary Supplement Health & Education Act "that structure/function claims be adequately substantiated" and also recommends FDA "include guidance in the final rule as to what constitutes adequate substantiation of a structure/function claim."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088797

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel